ENDO-ERN - European Reference Network on Rare Endocrinological Diseases
Rare endocrinological diseases are characterized by excessive, reduced or inappropriate hormone production, resistance to hormonal activity, neoplasms or genetic diseases of endocrine organs. Their epidemiological distribution is extremely variable, ranging from ultra-rare forms to conditions with low prevalence. Patients with rare endocrinological disease require highly specialized care, delivered by multi-disciplinary teams, coordinated by an endocrinologist.
Endo-ERN, the European network of centers dealing with rare diseases, includes eight sectors (defined as MTG, Main Thematic Group). The Padua hospital covers all eight MTGs envisaged:
- MTG1 – Adrenal;
- MTG2 - Disorders of Calcium & Phosphate Homeostasis;
- MTG3 - Genetic disorders of Glucose & Insulin Homeostasis;
- MTG4 - Genetic Endocrine Tumor Syndromes;
- MTG5 - Growth & Genetic Obesity Syndromes;
- MTG6 – Pituitary;
- MTG7 - Sex Development & Maturation;
- MTG8 – Thyroid.
Endo-ERN brings together the work of severalinstitutions, stakeholders, scientific societies, and European institutions, including the European Society of Endocrinology and the European Society of Pediatric Endocrinology.
The objective of endo-ERN is to improve the diagnostic-therapeutic pathways, the quality of care and the measurement of outcomes of patients with rare endocrinological diseases, involving family members and patient associations (ePAG, European Patient Advocacy Groups), facilitating collaboration and international multidisciplinary training.
Deputy Representative
Operating Units
Diseases
| ORPHA code | ERN code | Name |
|---|---|---|
| ORPHA:15 | Achondroplasia | |
| ORPHA:963 | Acromegaly | |
| ORPHA:99408 | Pituitary Adenoma | |
| ORPHA:91349 | Non-functioning pituitary adenoma | |
| ORPHA:2965 | Prolactin secreting adenoma | |
| ORPHA:91347 | TSH-secreting pituitary adenoma | |
| ORPHA:443287 | Cortisol producing adenomas | |
| ORPHA:116 | Beckwith-Wiedemann Syndrome | |
| ORPHA:306661 | Familial hyperphosphataemic tumoural calcinosis [ORPHA:306661] | |
| ORPHA:1501 | Adrenocortical carcinomas | |
| ORPHA:100088 | Non-metastatic thyroid carcinoma | |
| ORPHA:1359 | Carney Complex | |
| ORPHA:101952 | Rare diabetes | |
| ORPHA:325546 | Chromosomal DSD | |
| ORPHA:183631 | Thyroid hormone signaling disorders | |
| ORPHA:101959 | Primary Adrenal Insufficiency | |
| ORPHA:235936 | Familial hyperaldosteronism | |
| ORPHA:405 | Familial hypocalciuric hypercalcaemia | |
| ORPHA:300547 | PTH independent hypercalcaemia | |
| ORPHA:276525 | Hyperinsulinism | |
| ORPHA:181408 | Hyperparathyroidism including parathyroid cancer [ORPHA:181408] | |
| ORPHA:418 | Congenital adrenal hyperplasia | |
| ORPHA:424 | Congenital Hyperthyroidism | |
| ORPHA:436 | Hypophosphatasia | |
| ORPHA:89936 | X-linked hypophosphataemia | |
| ORPHA:478 | Isolated Congenital Anosmic Hypogonadotrophic Hypogonadism [ORPHA:478] | |
| ORPHA:432 | Isolated Congenital Normosmic Hypogonadotrophic Hypogonadism [ORPHA:432] | |
| ORPHA:181405 | Hypoparathyroidism | |
| ORPHA:95502 | Acquired Hypopituitarism | |
| ORPHA:95494 | Congenital Hypopituitarism | |
| ORPHA:442 | Congenital Hypothyroidism | |
| ORPHA:653 | MEN Type 2 | |
| ORPHA:652 | MEN Type 1 | |
| ORPHA:77828 | Rare Genetic Obesity | |
| ORPHA:666 | Osteogenesis imperfecta | |
| ORPHA:352540 | Oncogenic osteomalacia | |
| ORPHA:97593 | Pseudohypoparathyroidism | |
| ORPHA:289157 | Hypocalcaemic vitamin D dependent rickets | |
| ORPHA:93160 | Hypocalcaemic vitamin D resistant rickets | |
| ORPHA:437 | Hypophosphataemic rickets | |
| ORPHA:89937 | Autosomal dominant hypophosphataemic rickets [ORPHA:89937] | |
| ORPHA:289176 | Autosomal recessive hypophosphataemic rickets [ORPHA:289176] | |
| ORPHA:157215 | Hereditary hypophosphataemic rickets with hypercalciuria [ORPHA:157215] | |
| ORPHA:93460 | Overgrowth Syndrome | |
| ORPHA:553 | Cushing's Syndrome | |
| ORPHA:240 | Léri-Weill dyschondrosteosis | |
| ORPHA:648 | Noonan Syndrome | |
| ORPHA:739 | Prader Willi Syndrome and Prader Willi-like Syndrome [ORPHA:739] | |
| ORPHA:633 | GH Resistance syndromes | |
| ORPHA:813 | Silver Russell Syndrome | |
| ORPHA:892 | Von Hippel Lindau Syndrome (VHL) | |
| ORPHA:29072 | Hereditary PCC/PGL | |
| ORPHA:276624 | Sporadic PCC/PGL | |
| ORPHA:181368 | Insulin resistance syndrome | |
| ORPHA:3453 | autoimmune polyglandular syndrome | |
| ORPHA:3143 | autoimmune polyglandular syndrome | |
| ICD-10:F64 | Transgender, Female to male | |
| ICD-10:F64 | Transgender, Male to female | |
| ORPHA:2982 | XX DSD | |
| ORPHA:98085 | XY DSD |


